Viewing SEC Facts Units
Company Name:
Aclaris Therapeutics, Inc.
CIK:
1557746
Start Filing Date:
2019-01-01
End Filing Date:
2019-03-31
ACCN:
0001558370-19-004494
Value:
$ 41,248,663
Value Error:
$ None
Created By:
Date Filed:
2019-05-08
FY:
2019
Fiscal Period:
Q1
Frame:
CY2018Q1
Type:
us-gaap
Form:
10-Q
Units:
shares